Stock info Meridian Bioscience Inc | Filter  Basic-Info

Stock: Meridian Bioscience Inc (US broad)

Last Price 4.67 Max Price 4.67
Min Price 2.16 1 Year return 0.00
Sector Health Care Subsector Health Care Eq. & Services

Loading...

Contact info:Country: USAWebsite: www.meridianbioscience.com

Sector Review Meridian Bioscience Inc

Loading...
Year Turnover Total sector Market share
2019 0 1,914,856 0.00 %
2020 0 1,909,941 0.00 %
2021 0 2,244,427 0.00 %
2022 0 2,638,646 0.00 %
2023 0 2,748,111 0.00 %

Advice Meridian Bioscience Inc

No Records Found




News Meridian Bioscience Inc

No Records Found

Annual reports Meridian Bioscience Inc

No Records Found


Profile Meridian Bioscience Inc

Meridian Bioscience Inc


Meridian Bioscience Inc's core business is the health care eq. & services sector. The period from 2006 till the end of 2016 the international sector gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

The past year was a profitable year for the Meridian Bioscience Inc investors

Over the period from December 2015 till December 2016 the stock lost around 10 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 4 percent. Meridian Bioscience Inc's revenues between 2011 and 2015 were quite similar and moved between 173,54 million dollars and 194,83 million dollars. Meridian Bioscience Inc's net incomes between 2011 and 2015 were very volatile and moved between 26,83 million dollars and 35,54 million dollars.

The American company paid out dividends in the past 5 years. On average Meridian Bioscience Inc's dividend yield over the past 5 years was around 3,87 percent annually. In the period 2011 till 2015 Meridian Bioscience Inc paid it's investors each year a higher dividend per share. So we could call Meridian Bioscience Inc a kind of dividend aristocrat.

Meridian Bioscience Inc's balance mostly consists of debt

At the end of 2015 the health care company's balance sheet was worth 183,28 million dollars. Last year the total debt of the company was 17,41 million dollars. This equals around 9,5 percent of the total balance sheet. As per the end of 2015 Meridian Bioscience Inc's price/earnings-ratio equaled 19. So investors paid for 1 stock 19 times the earnings per share of 2015. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 828,6 million dollars. At the end of 2015 the American company had around 41,66 million stocks listed on the exchanges.

All Meridian Bioscience Inc's annual reports can be found here. More information about Meridian Bioscience Inc can be found it's website. .


Results Meridian Bioscience Inc

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Meridian Bioscience Inc

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Meridian Bioscience Inc

Details
2016
2017
2018
2019
2020
Price
0.0
0.0
0.0
0.0
4.67
Eps
0.0
0.0
0.0
0.0
Price/earnings-ratio
0.0
0.0
0.0
0.0
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
0.0
0.0
0.0
0.0
Market to book
0.0
0.0
0.0
0.0
Cashflow per stock
0.0
0.0
0.0
0.0
Stocks
0
0
0
0
Market Cap
0.00
0.00
0.00
0.00

Dividend Meridian Bioscience Inc


Price info Meridian Bioscience Inc

Date
Price
23 May 2026
4.67
01 May 2026
3.32
28 Apr 2026
3.40
21 Apr 2026
3.11
14 Apr 2026
2.55
01 Apr 2026
2.30
30 Mar 2026
2.52
28 Mar 2026
2.52
25 Mar 2026
2.16
24 Mar 2026
2.34
19 Mar 2026
2.44